SOUTHERN FINANCIAL, 1.I.0 ACCT. For the Period 8/1/13 to S/31/13 Note Unrealized Gain Loss is shown as "N. A" in cases where we do not have appropriate cost information for all tax lots comprising the position Please contact your J P Morgan learn (or additional information. Equity Detail Price Quantity Value Adjusted Cost Original Cost Unrealized GalnA.oss Est. Annual Inc. Accruec—liW7 Yield US Large Cap Equity ARIAD PHARMACEUTICALS INC 04033A-10-0 ARIA 18.60 16.535 000 307,551.00 290,997.40 16,553.60 BIOGEN IDEC INC 09062X-104 BNB 213.02 2,099.000 448,276.90 250,454.95 199,821.95 FACEBOOK 1NC-A 30303M-10-2 FB 41.29 17,500.000 722,645.00 665,000.00 67,645.00 GENERAL ELECTRIC CO 369604-10-3 GE 23.14 23,000.000 532,220.00 496,109.06 36,110.92 17,480.00 3.28% JPM VALUE ADVANTAGE FD -INSIL FUND 1400 4812A2-58-7 JVAI X 24.96 78,709.170 1.964.580.88 2,000,000.00 (35,419.12) 19,992.12 1.02% Total US Large Cap Equity US Small/Mid Cap Equity DEUTSCHE 8K AG LDN BRH DBL LONG ETN38 25154H-55-8 DAG 8.90 50,000.000 53,973,273.78 445800 00 53,702,561.43 352.529.00 $270,712.36 92,471.00 937,472.12 0.94% J.P Morgan Accounnage 5 of 48 Consolidated Statement Page 8 CONFIDENTIAL - PURSUANT TO FED. R. CRIM. P. 6(e) DB-SDNY-0 105116 CONFIDENTIAL SDNY_GM_00251300 EFTA01449662